Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection

BACKGROUND: The Belgian Superior Health Council (SHC) recently added a 13-valent pneumococcal conjugate vaccine (PCV13) to its recommendations for adult pneumococcal vaccination. This study addresses the policy question regarding whether a single dose of PCV13 should be reimbursed among Belgian adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Marbaix, Sophie, Peetermans, Willy E., Verhaegen, Jan, Annemans, Lieven, Sato, Reiko, Mignon, Annick, Atwood, Mark, Weycker, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034794/
https://www.ncbi.nlm.nih.gov/pubmed/29979689
http://dx.doi.org/10.1371/journal.pone.0199427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034794/
https://www.ncbi.nlm.nih.gov/pubmed/29979689
http://dx.doi.org/10.1371/journal.pone.0199427

Ejemplares similares